Invesco’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $193K | Buy |
42,833
+10,286
| +32% | +$46.4K | ﹤0.01% | 3516 |
|
|
2025
Q1 | $144K | Buy |
32,547
+17,624
| +118% | +$78.1K | ﹤0.01% | 3567 |
|
|
2024
Q4 | $117K | Buy |
14,923
+367
| +3% | +$2.87K | ﹤0.01% | 3589 |
|
|
2024
Q3 | $191K | Buy |
14,556
+329
| +2% | +$4.33K | ﹤0.01% | 3512 |
|
|
2024
Q2 | $172K | Buy |
14,227
+939
| +7% | +$11.3K | ﹤0.01% | 3648 |
|
|
2024
Q1 | $216K | Buy |
13,288
+27
| +0.2% | +$439 | ﹤0.01% | 3602 |
|
|
2023
Q4 | $90.4K | Buy |
13,261
+1,477
| +13% | +$10.1K | ﹤0.01% | 3688 |
|
|
2023
Q3 | $64.2K | Hold |
11,784
| – | – | ﹤0.01% | 3761 |
|
|
2023
Q2 | $80K | Sell |
11,784
-1,746
| -13% | -$11.9K | ﹤0.01% | 3748 |
|
|
2023
Q1 | $67.8K | Sell |
13,530
-819
| -6% | -$4.1K | ﹤0.01% | 3720 |
|
|
2022
Q4 | $70K | Sell |
14,349
-2,454
| -15% | -$12K | ﹤0.01% | 3857 |
|
|
2022
Q3 | $242K | Sell |
16,803
-98,499
| -85% | -$1.42M | ﹤0.01% | 3591 |
|
|
2022
Q2 | $1.75M | Buy |
115,302
+100,158
| +661% | +$1.52M | ﹤0.01% | 2752 |
|
|
2022
Q1 | $180K | Buy |
15,144
+111
| +0.7% | +$1.32K | ﹤0.01% | 3754 |
|
|
2021
Q4 | $244K | Sell |
15,033
-1,396
| -8% | -$22.7K | ﹤0.01% | 3669 |
|
|
2021
Q3 | $469K | Buy |
16,429
+2,563
| +18% | +$73.2K | ﹤0.01% | 3425 |
|
|
2021
Q2 | $468K | Buy |
13,866
+5,363
| +63% | +$181K | ﹤0.01% | 3421 |
|
|
2021
Q1 | $257K | Buy |
8,503
+2,169
| +34% | +$65.6K | ﹤0.01% | 3581 |
|
|
2020
Q4 | $314K | Buy |
+6,334
| New | +$314K | ﹤0.01% | 3377 |
|
|
2020
Q3 | – | Sell |
-85,061
| Closed | -$3.67M | – | 3655 |
|
|
2020
Q2 | $3.67M | Buy |
+85,061
| New | +$3.67M | ﹤0.01% | 2157 |
|